• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Rises 2%; Five Below Shares Plunge

    7/17/24 12:03:43 PM ET
    $ADTX
    $AEHR
    $ASLN
    $FIVE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Electrical Products
    Industrials
    Get the next $ADTX alert in real time by email

    U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 200 points on Wednesday.

    The Dow traded up 0.50% to 41,160.40 while the NASDAQ fell 2.46% to 18,053.81. The S&P 500 also fell, dropping, 1.15% to 5,601.75.

    Check This Out: Amazon To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday

    Leading and Lagging Sectors

    Real estate shares jumped by 1% on Wednesday.

    In trading on Wednesday, information technology shares fell by 3.2%.

    Top Headline

    U.S. crude oil inventories declined by 4.87 million barrels in the week ended July 12, falling for the third consecutive week, the EIA said.

    Equities Trading UP
                           

    • Aditxt, Inc. (NASDAQ:ADTX) shares shot up 28% to $2.04. Aditxt and Evofem amended merger agreement.
    • Shares of Aehr Test Systems (NASDAQ:AEHR) got a boost, surging 24% to $20.90 after the company reported better-than-expected Q4 financial results and issued FY25 revenue guidance above estimates. Also, the company announced it entered into a stock purchase agreement and made $12.7 million in orders for its FOX WaferPak full wafer Contractors.
    • Shimmick Corporation (NASDAQ:SHIM) shares were also up, gaining 58% to $2.04 after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.

    Equities Trading DOWN

    • ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) shares dropped 42% to $0.6339 after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation.
    • Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) were down 29% to $9.64 after announcing changes in executive leadership. The company named Rick Barry as Executive Chairman and Principal Executive Office and said Remi Barbier resigned as President, CEO, and Board Member.
    • Five Below, Inc. (NASDAQ:FIVE) was down, falling 21% to $80.80 after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.

    Also Check This Out: Alphabet, CrowdStrike And 2 Other Stocks Insiders Are Selling

    Commodities

    In commodity news, oil traded up 2.2% to $82.56 while gold traded up 0.1% at $2,469.20.

    Silver traded down 2.7% to $30.625 on Wednesday, while copper fell 0.9% to $4.4090.

    Euro zone

    European shares were mixed today. The eurozone's STOXX 600 fell 0.44%, Germany's DAX fell 0.36% and France's CAC 40 rose 0.02%. Spain's IBEX 35 Index rose 0.20%, while London's FTSE 100 rose 0.33%.

    Annual inflation rate in the Eurozone eased to 2.5% in June from 2.6% in May. French current account deficit shrank to EUR 3.1 billion in May versus a revised EUR 3.5 billion in the prior month.

    U.K. producer prices increased 1.4% year-over-year in June following a 1.7% rise in the prior month, while annual inflation rate came in steady at 2% in June.

    Asia Pacific Markets

    Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 0.43%, Hong Kong's Hang Seng Index gaining 0.06% and China's Shanghai Composite Index falling 0.45%.

    Singapore’s non-oil domestic exports fell by 8.7% year-over-year in June following a revised 0.7% decline in May.

    Economics

    • U.S. mortgage applications climbed by 3.9% during the third week of July.
    • U.S. housing starts increased by 3% from the prior month to an annualized rate of 1,314,000 in June compared to a revised 4.6% fall a month ago.
    • Building permits in the U.S. climbed by 3.4% to an annual rate of 1.446 million in June.
    • Industrial production in the U.S. climbed 0.6% from a month ago in June compared to market estimates of a 0.3% gain.
    • U.S. crude oil inventories declined by 4.87 million barrels in the week ended July 12, falling for the third consecutive week, the EIA said.

    Now Read This: How To Earn $500 A Month From Domino’s Stock Ahead Of Q2 Earnings Report

    Get the next $ADTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADTX
    $AEHR
    $ASLN
    $FIVE

    CompanyDatePrice TargetRatingAnalyst
    Five Below Inc.
    $FIVE
    2/4/2026$233.00Underperform → Buy
    BofA Securities
    Five Below Inc.
    $FIVE
    1/13/2026$210.00Buy → Hold
    Jefferies
    Five Below Inc.
    $FIVE
    1/13/2026$195.00 → $240.00Outperform
    Telsey Advisory Group
    Five Below Inc.
    $FIVE
    1/8/2026$242.00Hold → Buy
    Deutsche Bank
    Shimmick Corporation
    $SHIM
    1/5/2026$6.00Hold → Buy
    Craig Hallum
    Aehr Test Systems
    $AEHR
    12/17/2025$29.00Buy
    Lake Street
    Five Below Inc.
    $FIVE
    12/8/2025$216.00Hold → Buy
    Truist
    Five Below Inc.
    $FIVE
    12/4/2025$170.00 → $195.00Outperform
    Telsey Advisory Group
    More analyst ratings

    $ADTX
    $AEHR
    $ASLN
    $FIVE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Five Below upgraded by BofA Securities with a new price target

    BofA Securities upgraded Five Below from Underperform to Buy and set a new price target of $233.00

    2/4/26 8:24:40 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Five Below downgraded by Jefferies with a new price target

    Jefferies downgraded Five Below from Buy to Hold and set a new price target of $210.00

    1/13/26 9:05:21 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on Five Below with a new price target

    Telsey Advisory Group reiterated coverage of Five Below with a rating of Outperform and set a new price target of $240.00 from $195.00 previously

    1/13/26 8:19:44 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADTX
    $AEHR
    $ASLN
    $FIVE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer's Disease in the Journal of Prevention of Alzheimer's Disease

    As previously disclosed, the studies did not meet pre-specified co-primary, secondary, or exploratory biomarker endpoints  The paper provides a detailed analysis of the RETHINK-ALZ and REFOCUS-ALZ studies and confirms simufilam's favorable safety profile in these studies Exploratory post-hoc analyses offer informative insights AUSTIN, Texas, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA, "Cassava", the "Company")), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced publication of the article Phase 3 randomized clinica

    1/13/26 8:00:00 AM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Five Below, Inc. Announces Holiday Sales Results for Quarter-To-Date Through January 3, 2026

    Net Sales Increase of 23.2% to $1.5 Billion; Comparable Sales Increase of 14.5% Increases Fourth Quarter and Full Year Fiscal 2025 Outlook PHILADELPHIA, PA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE) ("Five Below" or the "Company") today announced net sales results for the quarter-to-date period from November 2, 2025 through January 3, 2026 ("Holiday Period"). Net sales for the Holiday Period increased by 23.2% to $1.47 billion from $1.19 billion in the comparable nine-week period from November 3, 2024 through January 4, 2025. Comparable sales for the Holiday Period increased by 14.5%. Winnie Park, CEO of Five Below, stated, "We are incredibly pleased with our holi

    1/12/26 7:00:00 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Five Below, Inc. Announces Participation in the 2026 ICR Conference

    PHILADELPHIA, PA, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE), the trend-right, high-quality extreme-value retailer for the kid and the kid in all of us, today announced that management is currently scheduled to host a fireside chat at the 2026 ICR Conference in Orlando, Florida, on Monday, January 12, 2026, at 10:00 a.m. Eastern Time. The fireside chat will be webcast live at http://investor.fivebelow.com/. An archived replay will be available two hours after the conclusion of the live event. The company plans to release its holiday sales results on January 12, 2026, prior to the market open. About Five Below: Five Below is a leading growth retailer offering trend-

    12/22/25 4:01:00 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADTX
    $AEHR
    $ASLN
    $FIVE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    VP Contactor Business Unit Sporck Alistair N sold $82,716 worth of shares (3,000 units at $27.57), decreasing direct ownership by 11% to 25,153 units (SEC Form 4)

    4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

    2/10/26 4:17:52 PM ET
    $AEHR
    Electrical Products
    Industrials

    Director Slayen Howard T gifted 15,000 shares, decreasing direct ownership by 7% to 203,328 units (SEC Form 4)

    4 - AEHR TEST SYSTEMS (0001040470) (Issuer)

    2/4/26 8:34:46 PM ET
    $AEHR
    Electrical Products
    Industrials

    Director Vaughn Mimi Eckel was granted 113 shares, increasing direct ownership by 2% to 4,766 units (SEC Form 4)

    4 - FIVE BELOW, INC (0001177609) (Issuer)

    2/4/26 4:19:37 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADTX
    $AEHR
    $ASLN
    $FIVE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Financial Officer Yoder Todd Wilbur bought $5,600 worth of shares (2,000 units at $2.80) (SEC Form 4)

    4/A - Shimmick Corp (0001887944) (Issuer)

    12/2/25 4:18:47 PM ET
    $SHIM
    Military/Government/Technical
    Industrials

    Director Anderson Robert Eugene Jr bought $24,940 worth of shares (8,600 units at $2.90) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/25/25 4:06:25 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Barry Richard bought $414,000 worth of shares (150,000 units at $2.76) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/24/25 4:02:17 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AEHR
    $ASLN
    $FIVE
    SEC Filings

    View All

    SEC Form 8-K filed by Five Below Inc.

    8-K - FIVE BELOW, INC (0001177609) (Filer)

    2/9/26 4:32:55 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    SEC Form SCHEDULE 13G filed by Aditxt Inc.

    SCHEDULE 13G - Aditxt, Inc. (0001726711) (Subject)

    1/30/26 8:02:33 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aditxt Inc. filed SEC Form 8-K: Other Events

    8-K - Aditxt, Inc. (0001726711) (Filer)

    1/30/26 4:23:38 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADTX
    $AEHR
    $ASLN
    $FIVE
    Leadership Updates

    Live Leadership Updates

    View All

    Cassava Reports Q3 2025 Financials Results and Provides Business Update

    Simufilam advancing towards a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyFurther fortified our strategic capabilities with the appointment of Dawn C. Bir to the Board of Directors$106.1 million in cash and cash equivalents at September 30, 2025. Expected to support operations into 2027 AUSTIN, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- – Cassava Sciences, Inc. (NASDAQ:SAVA, "Cassava", the "Company")), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as Tuberous Sclerosis Complex (TSC)-related epilepsy, today reported financial results for the third quarter ende

    11/12/25 8:00:00 AM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

    AUSTIN, Texas, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ:SAVA, "Cassava", the "Company")), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced the appointment of Ms. Dawn C. Bir to its Board of Directors (the Board). Dawn Bir is a seasoned biopharmaceutical executive and board member with a track record of contributing to the successful development and value creation for pre-commercial and commercial biotechnology and life science companies including Reata Pharmaceuticals, Inc. (acquired by Biogen Inc.), Geron Corporation,

    10/22/25 8:00:00 AM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Five Below Appoints Chief Financial Officer and Chief Merchandising Officer

    PHILADELPHIA, PA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE) ("Five Below" or "the Company"), the trend-right, high-quality, extreme-value retailer for the kid and the kid in all of us, today announced the appointments of Daniel Sullivan as Chief Financial Officer (CFO) and Michelle Israel as Chief Merchandising Officer (CMO), effective October 6, 2025. Both executives will report to Winnie Park, Chief Executive Officer. Mr. Sullivan will be responsible for Five Below's financial operations and related strategies, overseeing its Finance, Information Technology and Asset Protection teams. Ms. Israel will be responsible for Merchandising, Planning, Allocation, Product S

    10/1/25 9:25:00 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    $ADTX
    $AEHR
    $ASLN
    $FIVE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Five Below Inc.

    SC 13G/A - FIVE BELOW, INC (0001177609) (Subject)

    11/14/24 1:28:32 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Five Below Inc.

    SC 13G/A - FIVE BELOW, INC (0001177609) (Subject)

    11/14/24 1:22:35 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Aehr Test Systems

    SC 13G/A - AEHR TEST SYSTEMS (0001040470) (Subject)

    11/12/24 1:33:55 PM ET
    $AEHR
    Electrical Products
    Industrials

    $ADTX
    $AEHR
    $ASLN
    $FIVE
    Financials

    Live finance-specific insights

    View All

    Five Below, Inc. Announces Third Quarter Fiscal 2025 Financial Results

    Q3 Net Sales Increase of 23.1% to $1.0 Billion; Comparable Sales Increase of 14.3% Q3 GAAP Diluted EPS of $0.66, Q3 Adjusted Diluted EPS of $0.68 Increases Full Year 2025 Sales and EPS Outlook PHILADELPHIA, PA, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE) today announced financial results for the third quarter and year to date period ended November 1, 2025. For the third quarter ended November 1, 2025: Net sales increased by 23.1% to $1,038.3 million from $843.7 million in the third quarter of fiscal 2024; comparable sales increased by 14.3%.The Company opened 49 net new stores and ended the quarter with 1,907 stores in 44 states. This represents an increase in sto

    12/3/25 4:01:00 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Five Below, Inc. Announces Third Quarter 2025 Earnings Release and Conference Call Date

    PHILADELPHIA, PA, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE), the trend-right, extreme-value brand for kids, today announced that its financial results for the third quarter of fiscal 2025 will be released after market close on Wednesday, December 3, 2025. The company will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results. A live audio webcast of the conference call will be available online at investor.fivebelow.com, where a replay will be available shortly after conclusion of the call. Investors and analysts interested in participating in the call are invited to dial 412-902-6753 approximately 10 minutes prior to the start of the call

    11/19/25 4:01:00 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Shimmick Corporation Announces Third Quarter 2025 Results

    IRVINE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ:SHIM), a leading infrastructure solutions provider in water, electrical and other critical infrastructure construction services, today announced financial results for the third quarter ended October 3, 2025. Third Quarter 2025 and Recent Highlights Reported revenue of $142 million, with $107 million coming from Shimmick Projects Shimmick Projects revenue up 6% year over yearTotal revenue up 5% year over year when excluding the one-time favorable Non-Core Project claim settlement revenue of $31 million recorded during Q3 2024 Reported gross margin of $11 million, with $10 million coming from Shimmick Projects Gross m

    11/13/25 4:05:00 PM ET
    $SHIM
    Military/Government/Technical
    Industrials